1093 related articles for article (PubMed ID: 11162373)
1. Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes.
Nyame AK; Leppänen AM; Bogitsh BJ; Cummings RD
Exp Parasitol; 2000 Dec; 96(4):202-12. PubMed ID: 11162373
[TBL] [Abstract][Full Text] [Related]
2. Mice infected with Schistosoma mansoni generate antibodies to LacdiNAc (GalNAc beta 1-->4GlcNAc) determinants.
Nyame AK; Leppanen AM; DeBose-Boyd R; Cummings RD
Glycobiology; 1999 Oct; 9(10):1029-35. PubMed ID: 10521539
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of LacdiNAc, fucosylated LacdiNAc, and Lewis x glycan antigens in intramolluscan stages of Schistosoma mansoni.
Nyame AK; Yoshino TP; Cummings RD
J Parasitol; 2002 Oct; 88(5):890-7. PubMed ID: 12435126
[TBL] [Abstract][Full Text] [Related]
4. Immunity to schistosomiasis: glycans are potential antigenic targets for immune intervention.
Nyame AK; Lewis FA; Doughty BL; Correa-Oliveira R; Cummings RD
Exp Parasitol; 2003; 104(1-2):1-13. PubMed ID: 12932753
[TBL] [Abstract][Full Text] [Related]
5. Targeted identification of a unique glycan epitope of Schistosoma mansoni egg antigens using a diagnostic antibody.
Robijn ML; Koeleman CA; Wuhrer M; Royle L; Geyer R; Dwek RA; Rudd PM; Deelder AM; Hokke CH
Mol Biochem Parasitol; 2007 Feb; 151(2):148-61. PubMed ID: 17188765
[TBL] [Abstract][Full Text] [Related]
6. Dominant antibody responses to Fucalpha1-3GalNAc and Fucalpha1-2Fucalpha1-3GlcNAc containing carbohydrate epitopes in Pan troglodytes vaccinated and infected with Schistosoma mansoni.
van Remoortere A; Vermeer HJ; van Roon AM; Langermans JA; Thomas AW; Wilson RA; van die I; van den Eijnden DH; Agoston K; Kérèkgyarto J; Vliegenthart JF; Kamerling JP; van dam GJ; Hokke CH; Deelder AM
Exp Parasitol; 2003; 105(3-4):219-25. PubMed ID: 14990315
[TBL] [Abstract][Full Text] [Related]
7. Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite.
Prasanphanich NS; Luyai AE; Song X; Heimburg-Molinaro J; Mandalasi M; Mickum M; Smith DF; Nyame AK; Cummings RD
Glycobiology; 2014 Jul; 24(7):619-37. PubMed ID: 24727440
[TBL] [Abstract][Full Text] [Related]
8. Repeats of LacdiNAc and fucosylated LacdiNAc on N-glycans of the human parasite Schistosoma mansoni.
Wuhrer M; Koeleman CA; Deelder AM; Hokke CH
FEBS J; 2006 Jan; 273(2):347-61. PubMed ID: 16403022
[TBL] [Abstract][Full Text] [Related]
9. Vaccination-induced protection of lambs against the parasitic nematode Haemonchus contortus correlates with high IgG antibody responses to the LDNF glycan antigen.
Vervelde L; Bakker N; Kooyman FN; Cornelissen AW; Bank CM; Nyame AK; Cummings RD; van Die I
Glycobiology; 2003 Nov; 13(11):795-804. PubMed ID: 12907692
[TBL] [Abstract][Full Text] [Related]
10. Chemoenzymatic synthesis of multivalent neoglycoconjugates carrying the helminth glycan antigen LDNF.
Tefsen B; van Stijn CM; van den Broek M; Kalay H; Knol JC; Jimenez CR; van Die I
Carbohydr Res; 2009 Aug; 344(12):1501-7. PubMed ID: 19541294
[TBL] [Abstract][Full Text] [Related]
11. Saposin-like proteins are expressed in the gastrodermis of Schistosoma mansoni and are immunogenic in natural infections.
Don TA; Bethony JM; Loukas A
Int J Infect Dis; 2008 Nov; 12(6):e39-47. PubMed ID: 18571965
[TBL] [Abstract][Full Text] [Related]
12. Antibodies elicited by the secretions from schistosome cercariae and eggs are predominantly against glycan epitopes.
Kariuki TM; Farah IO; Wilson RA; Coulson PS
Parasite Immunol; 2008 Oct; 30(10):554-62. PubMed ID: 18786069
[TBL] [Abstract][Full Text] [Related]
13. Presence of the LDNF glycan on the host-protective H-gal-GP fraction from Haemonchus contortus.
Geldhof P; Newlands GF; Nyame K; Cummings R; Smith WD; Knox DP
Parasite Immunol; 2005; 27(1-2):55-60. PubMed ID: 15813723
[TBL] [Abstract][Full Text] [Related]
14. Human antibody responses to Schistosoma mansoni: the influence of epitopes shared between different life-cycle stages on the response to the schistosomulum.
Dunne DW; Grabowska AM; Fulford AJ; Butterworth AE; Sturrock RF; Koech D; Ouma JH
Eur J Immunol; 1988 Jan; 18(1):123-31. PubMed ID: 2450028
[TBL] [Abstract][Full Text] [Related]
15. Protective monoclonal antibodies from mice vaccinated or chronically infected with Schistosoma mansoni that recognize the same antigens.
Gregoire RJ; Shi MH; Rekosh DM; Loverde PT
J Immunol; 1987 Dec; 139(11):3792-801. PubMed ID: 2445819
[TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni: the circulating cathodic antigen forms an abundant product of 41/42 kDa in the urine of infected patients.
Abdeen HH; Attallah AF; El-Mohamady HI; Harrison RA; Mansour MM
Exp Parasitol; 1998 Nov; 90(3):286-9. PubMed ID: 9806874
[No Abstract] [Full Text] [Related]
17. Schistosome antigen gp50 is responsible for serological cross-reactivity with Trichinella spiralis.
Linder E; Thors C; Lundin L; Ljungström I; Farah S; Hagi H; Dias F
J Parasitol; 1992 Dec; 78(6):999-1005. PubMed ID: 1491314
[TBL] [Abstract][Full Text] [Related]
18. Schistosoma mansoni infection in humans and primates induces cytolytic antibodies to surface Le(x) determinants on myeloid cells.
Nyame AK; Pilcher JB; Tsang VC; Cummings RD
Exp Parasitol; 1996 Mar; 82(2):191-200. PubMed ID: 8617346
[TBL] [Abstract][Full Text] [Related]
19. Schistosoma mansoni antigens applicable to diagnosis of prepatent infections.
Mikhail MM; Mansour MM; Farid Z; Harrison R
J Egypt Soc Parasitol; 1997 Apr; 27(1):1-20. PubMed ID: 9097522
[TBL] [Abstract][Full Text] [Related]
20. Schistosoma mansoni: immunoreactivity of human sera with the surface antigen Sm23.
Köster B; Hall MR; Strand M
Exp Parasitol; 1993 Nov; 77(3):282-94. PubMed ID: 8224084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]